Understanding Your Laboratory Test: What It Is, How It Is Done, and What Your Results Mean for Your Health
This test checks if a newborn's first stool (meconium) contains amphetamine-type stimulants, which can indicate maternal drug use during pregnancy.
{"Detects amphetamine and methamphetamine exposure in newborns","Uses the baby's first stool (meconium) as the sample","Helps identify prenatal drug exposure for proper medical care","Positive results may require follow-up testing and intervention","Results are typically available within a few days"}
Key facts at a glance
- LOINC
- 8146-3
- Short code
- Amphetamines Mec Ql Scn
- Synonyms
- Amphetamines Mec Ql Scn
- Category
- chemistry
- Sample
- serum
- Container
- Red-top tube (SST)
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- screen
- Specimen volume
- 5 mL
- Stability
- Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 4–24 hours
- Order
- routine
This test is a laboratory analysis, usually performed on a small sample of your blood, urine, or other body tissue, that helps your doctor evaluate how well your body is functioning. The results can show whether your organs are working normally, whether an infection or other condition may be present, and how well a current treatment is working for you.
The Amphetamines Screening Test in Meconium is a laboratory test that detects the presence of amphetamine-type stimulants in a newborn's first stool, called meconium. This test uses a screening method to identify whether the baby was exposed to drugs like amphetamine or methamphetamine during pregnancy. Meconium begins to form around the 12th week of pregnancy and accumulates drugs and their metabolites that cross the placenta, making it an ideal sample for detecting long-term fetal drug exposure.
A trained health professional typically draws a small amount of blood from a vein in your arm using a thin needle, a process that usually takes only a few minutes. Depending on the test, you may instead be asked to provide a urine sample. Some tests require no preparation, while others may ask you to fast or avoid certain foods and medicines beforehand.
A small sample of meconium is collected from the baby's diaper and sent to a laboratory for analysis. The screening method used is immunoassay-based, which can detect the presence of amphetamine-class drugs. If the screening test is positive, confirmatory testing (such as mass spectrometry) may be performed to verify the results and identify the specific substances.
Your doctor may order this test as part of a routine checkup, to help find the cause of symptoms you are experiencing, to screen for conditions before they cause problems, or to monitor an ongoing condition and track how well your treatment plan is working over time.
This test is commonly ordered when healthcare providers suspect that a mother may have used amphetamine-type drugs during pregnancy. It helps healthcare teams identify infants who may need special care due to drug exposure, including monitoring for withdrawal symptoms and developmental issues. Early detection allows for appropriate intervention and support services for both the baby and family.
Your results are compared with established reference ranges, and values within those ranges are generally considered typical for a healthy person. Values outside the expected range do not automatically mean you are ill, since factors such as age, medications, diet, and stress can affect results. Your doctor will interpret your numbers together with your medical history and may recommend additional testing if needed.
A negative result suggests no detectable amphetamine-type drugs were found in the meconium sample. A positive result indicates that the baby was exposed to amphetamine or related drugs during pregnancy. It's important to remember that a positive result does not necessarily mean the mother used drugs after birth – only that exposure occurred during pregnancy. Healthcare providers will discuss results with families and recommend appropriate follow-up care.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
This test is clinically significant for identifying prenatal exposure to amphetamine-type stimulants, which can affect newborn health and development. Babies exposed to these drugs during pregnancy may experience neonatal abstinence syndrome (NAS), growth problems, developmental delays, and other health issues. Early identification allows healthcare providers to monitor these infants closely and provide necessary interventions. The test also helps social services and healthcare teams provide appropriate support and resources to affected families. Additionally, positive results may prompt investigation into the mother's health and provide opportunities for addiction treatment and counseling.
Frequently asked questions
Is this test mandatory?
Will I be informed of the results?
What happens if the test is positive?
Can a positive result affect my parental rights?
How long does it take to get results?
Sources
- 1
- 2
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy